The Efficacy of Beta-Blockers in Patients With Long QT Syndrome 1-3 According to Individuals' Gender, Age, and QTc Intervals: A Network Meta-analysis.

Han, Lu; Liu, Fuxiang; Li, Qing; Qing, Tao; Zhai, Zhenyu; Xia, Zirong; Li, Juxiang

Han, Lu; Liu, Fuxiang; Li, Qing; Qing, Tao; Zhai, Zhenyu; Xia, Zirong; Li, Juxiang.

Afiliación

Han L; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Liu F; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Li Q; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Qing T; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zhai Z; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Xia Z; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Li J; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

Front Pharmacol ; 11: 579525, 2020.

Article en En | MEDLINE | ID: mdl-33381033

Palabras clave

atenolol; beta-blockers; cardiac events; metoprolol; nadolol; propranolol

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Aspecto: Determinantes_sociais_saude Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google